During this year’s World Antimicrobial Resistance Awareness Week, the World Health Organization (WHO) warned that antimicrobial resistance (AMR) jeopardizes decades of medical progress, noting that bacterial drug resistance was associated with an estimated 4.7 million deaths globally in 2021, with sub-Saharan Africa experiencing the highest AMR-associated mortality rates.

WHO Regional Director for Africa, Dr. Mohamed Janabi, sounded the alarm, stating that medicines relied upon for generations are losing their effectiveness, making infections harder to treat and endangering millions of lives.

In his message for the awareness week, Dr. Janabi observed that the discovery of penicillin and other antibiotics revolutionized medicine, turning once-fatal infections into treatable conditions and making surgery, cancer treatment, and organ transplantation safer.

However, he cautioned that these medical advances are now under threat.

“Today, antimicrobial resistance threatens these gains. Medicines we have relied on for generations are losing their effectiveness, making infections harder to treat and putting lives at risk across our region,” he said.

Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites no longer respond to the medicines designed to treat the infections they cause.

The WHO Regional Director announced that the 2026 awareness week, scheduled for November 18–24, will be observed under the theme “One Health, One Action: Prevent AMR Now,” emphasizing the interconnectedness of human, animal, plant, and environmental health.

He noted that inappropriate use of antimicrobials in humans and animals accelerates resistance, while poor infection prevention, inadequate water and sanitation, and unsafe waste disposal contribute to the spread of resistant organisms.

He stressed that addressing these factors must be the centerpiece of efforts to contain the growing threat.

Providing an update on regional progress, Dr. Janabi disclosed that all 47 member states in the WHO African Region now have national action plans on AMR, though implementation remains uneven.

He added that all 47 countries are enrolled in WHO’s Global Antimicrobial Resistance and Use Surveillance System, while 44 have the capacity to conduct susceptibility testing for priority bacterial pathogens.

These tests help determine which antibiotics are likely to work against specific infections, supporting more effective treatment decisions.

Dr. Janabi further reported that 36 countries have adopted WHO’s Access, Watch, and Reserve classification of antibiotics to promote appropriate prescribing and responsible use.

The classification supports the global target of ensuring that at least 70 percent of antibiotics used in human health come from the Access group by 2030.

Regarding the One Health approach, he said the number of countries with functional multisectoral AMR governance mechanisms increased from 15 in 2023 to 29 in 2026.

“These arrangements clarify responsibilities and help sectors plan and act together,” he said.

Commending member states and regional partners—including the Food and Agriculture Organization of the United Nations, the United Nations Environment Programme, and the World Organisation for Animal Health—for their collaboration, Dr. Janabi stressed the need to translate existing commitments into practical protection for communities.

“Preventing infections reduces the need for antimicrobials. Clean water, sanitation, good hygiene, vaccination, and effective infection prevention in health facilities and farms are essential. Safe management of waste and wastewater also merits greater attention,” he said.

He called on African governments to move beyond developing national action plans to ensuring their implementation through adequate funding, clear responsibilities, and measurable results.

“Domestic investment must support laboratories, surveillance, and the appropriate use of antimicrobials, while ensuring that people can access quality-assured treatment when they need it,” he said.

The WHO official also urged health professionals, animal health workers, and agricultural practitioners to prevent infections and use antimicrobials responsibly.

He called on researchers, industry, and development partners to support national priorities, expand equitable access to diagnostics and treatments, and strengthen the evidence needed to guide interventions.

Dr. Janabi said communities, young people, educators, and the media also have important roles to play in improving understanding of AMR.

He advised the public to keep vaccinations up to date, practice good hand hygiene, use antibiotics only when prescribed by qualified health professionals, and never share leftover medicines.

“WHO will continue working alongside countries and partners to strengthen the One Health response and protect the medicines that make so much of modern health care possible,” he said.

Emphasizing that the fight against AMR requires collective responsibility, Dr. Janabi added: “AMR is everyone’s business. Let us each choose one concrete action this week, sustain it throughout the year, and encourage others to act.”

“Through our individual choices and collective commitment, we can help ensure that lifesaving medicines work when we need them, now and for generations to come.”

Source link

Exit mobile version